Aptamers Market - Trends Forecast Till 2028

Aptamers, by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-PH-AM-325


Number of Pages: 350

Domain: Pharmaceutical

Aptamers Market – Trends Forecast Till 2028

The global Aptamers market size is projected to reach USD 343 million by 2026 at a CAGR of 17.8% from USD 151 million in 2021 during the forecast period 2021-2028.

Aptamers are single stranded oligonucleotides that have an ability to fold themselves and bind to a specific protein. This ability of binding to desired protein enables them for therapeutic use where their binding ability is exploited to inhibit protein-protein interactions. They provide an advantage over antibodies as the aptamer generation is relatively easier than the production of antibodies and is significantly cheaper as well.

With the surge in number of conducted clinical trials along with the increased awareness of advantages of aptamer over antibodies are some of the factors that have supported long-term expansion for Aptamers.

The COVID-19 pandemic which is an infectious disease led to an increased R&D in the sector for enabling the use of aptamers in the diagnostic kits for the virus detection. The example for the development and use could be the highly specialised aptamer for spike protein of COVID-19 which was developed by NeoVentures Biotechnology.

Aptamers Market Analysis

Asia Pacific is expected to be the largest market of aptamers due to the recent R&D on aptamers along with the need of the development of aptamer-based products. Amongst Asia pacific North America is expected to have the largest share of the market which is attributed to the increased financial investment into the sector.

Aptamers is segmented into Product Type, Technology, Application, End Users and geography.

On the basis of Type                                               

  • DNA Aptamers
  • XNA Aptamers
  • RNA Aptamers

On the basis of Technology

  • Others

On the basis of Application

  • Therapeutics Development
  • Research & Development
  • Diagnostic
  • Others

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

On the basis of End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Research Institutes
  • CROs
  • Others

Detailed qualitative and quantitative data & insights are provided on global, regional and country level.

Aptamers Market Primary Respondent

Key players

  • Aptamer Group
  • Aptamer Sciences Inc.
  • Raptamer Discovery Group
  • SomaLogic Inc.
  • Aptagen LLC
  • Maravai Lifesciences
  • Kaneka Corporation
  • NeoVentures Biotechnology Inc.
  • Aptus Biotech
  • Base Pair Biotechnologies
  • Novaptech
  • Bio-Techne

Recent Developments

  • In July 2021, Korean government selected Aptamer Sciences, Inc. to support a non-clinical project for the development of a new drug and vaccine for COVID-19 and is entitled to receive a research grant of about USD 0.51 million for an year.
  • In August 2021, Aptamer Group partnered with ProAxsis Limited. As per the partnership, Aptamer Group will develop validated Optimer ligands against critical targets for ProAxsis’s diagnostic assays.
  • In August 2021, Aptamer Group, Ltd along with BizCom Japan, Inc. entered into  a distribution and marketing agreement.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Aptamers so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope


Report Feature


Market Revenue In 2021

USD 151 million

Growth Rate

CAGR of 17.8% during the forecasting period, 2021-2028

Historical Data


Forecast Years


Base Year


Units Considered

Revenue in USD million and CAGR from 2021 to 2028

Report Segmentation

Product Type, Technology, Application, End Users and geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Aptamer Group, Aptamer Sciences, Inc., Raptamer Discovery Group, SomaLogic Inc., and Aptagen, LLC

Available Customization

In addition to the market data for Aptamers, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.

Regional Report

Note: Report data and information will be by Country.

Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.